M1A.2721 Drug-induced chronic gout, left ankle and foot, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Left Ankle and Foot, with Tophus (tophi)

Summary

Drug-induced chronic gout, left ankle and foot, with tophus (tophi) is a form of arthritis affecting the left ankle and foot joints, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the affected area.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left ankle and foot joints and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense left ankle or foot pain, often with swelling and redness
• Persistent warmth and tenderness in the affected joints
• Formation of tophi (hard, painless lumps) around the left ankle or foot
• Stiffness and limited range of motion in the affected joints
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history (including medication use), and laboratory tests to measure uric acid levels. Imaging studies, such as X-rays or ultrasound, may be used to detect tophi or joint damage. Joint fluid analysis can confirm the presence of urate crystals.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. This may include discontinuing or adjusting the causative medication, using urate-lowering therapies (e.g., allopurinol), and prescribing anti-inflammatory drugs for flare-ups. In some cases, medications to dissolve tophi or surgery to remove them may be considered.

Prognosis and Follow-Up

With appropriate management, symptoms can be controlled, and further joint damage may be prevented. Regular follow-up is important to monitor uric acid levels, adjust treatments, and address any complications. Long-term adherence to therapy is often necessary to maintain remission.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, persistent pain, and increased tophi formation. Severe cases can result in deformity, reduced mobility, or kidney problems due to uric acid accumulation.

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible.
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood).
• Stay hydrated to support uric acid excretion.
• Manage weight and limit alcohol intake, which can exacerbate gout.

When to Seek Professional Help

Seek medical attention if you experience severe or worsening joint pain, swelling, or redness in the left ankle or foot, or if tophi are noticed. Prompt evaluation is important to prevent further damage and adjust treatment as needed.

Tips for Medical Coders

This code specifies drug-induced chronic gout affecting the left ankle and foot, with the presence of tophi. Ensure documentation confirms the anatomic site (left ankle and foot) and the presence of tophi. Code M1A.2721 is used when the condition is chronic, drug-induced, and involves tophi in the specified location. Verify that the underlying cause (medication) and chronicity are clearly documented to support accurate coding.